Skip to main content

Year: 2026

Vornado Realty Trust Completes Acquisition of 49% Interest in Park Avenue Plaza 

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE:VNO) announced today that it has completed its previously announced acquisition of a 49% interest in Park Avenue Plaza. The property was acquired at a gross valuation of $1.1 billion ($950 per square foot), a significant discount to replacement cost. Park Avenue Plaza is a 45-story, 1.2 million rentable square foot building located at 55 East 52nd Street. The trophy, Class A office building, co-owned by Fisher Brothers, has protected Park Avenue views and occupies the full through-block between East 52nd and East 53rd Street. The property is located directly across 52nd Street from Vornado’s 350 Park Avenue development. Park Avenue Plaza is 99% occupied by blue-chip tenants with an 11-year weighted-average lease term and substantially below-market rents. Vornado...

Continue reading

L.B. Foster Company to Present Virtually at Sidoti Small Cap Conference on June 18, 2026

PITTSBURGH, Pa., June 11, 2026 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR, the “Company”), announced today that Bill Thalman, Executive Vice President and Chief Operating Officer, and Sean Reilly, Senior Vice President and Chief Financial Officer, will present virtually at the Sidoti Small Cap Virtual Conference on June 18, 2026, beginning at 10:45 AM EDT. Presentation materials for the conference will be posted on the Company’s Investor Relations website under “Presentations” the morning of the conference. A video webcast and a video replay will be available online. A webcast registration link will be available on the L.B. Foster website: www.lbfoster.com, under the Investor Relations page, on the day of the event. Video replay will remain available for 90 days. About L.B. Foster CompanyFounded in 1902, L.B. Foster Company...

Continue reading

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Second Quarter 2026

EXTON, Pa., June 11, 2026 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on July 7, 2026, to shareholders of record on June 23, 2026. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend. INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS – This press release contains forward-looking statements, which are subject to inherent uncertainties which are difficult to predict...

Continue reading

Adamas Trust Declares Second Quarter 2026 Common Stock Dividend of $0.27 Per Share, and Preferred Stock Dividends

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) — Adamas Trust, Inc. (Nasdaq: ADAM) (the “Company” or “Adamas”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.27 per share on shares of its common stock for the quarter ending June 30, 2026. The dividend will be payable on July 28, 2026 to common stockholders of record as of the close of business on June 23, 2026. In addition, the Board declared cash dividends on the Company’s 8.000% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”), 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series E Preferred Stock”), 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”) and 7.000% Series G Cumulative Redeemable...

Continue reading

Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2026 Results

March 31, 2026 Quarter Highlights:Net earnings of $9.2 million; EBITDA of $15.2 million Sales of $191.8 million Record quarterly sales volume 6% increase in sales volume over the preceding third quarter 14% increase in sales volume over the prior year fourth quarterFiscal Year March 31, 2026 Highlights:Net earnings of $19.5 million; EBITDA of $34.3 million Sales of $646.9 million – 46% increase over the prior fiscal year Record annual sales volume 22% increase in sales volume over the prior fiscal yearLONGVIEW, Texas, June 11, 2026 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NASDAQ/GS: FRD) announced today its results of operations for the quarter and fiscal year ended March 31, 2026. “We delivered an outstanding fourth quarter and a strong finish to fiscal 2026 as our strategic investments and operating initiatives...

Continue reading

NevGold Announces Completion of Debt Settlement

Vancouver, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) announces that, further to its press release dated May 21, 2026, it has completed its debt settlement with Mercer Street Global Opportunity Fund II, LP, managed by C/M Global GP, LLC (“Mercer”). The Company issued 227,544 common shares of the Company (each, a “Common Share”) to Mercer, at an issue price of $2.44 per Common Share, in settlement of accrued original issue discount on the Company’s convertible security (the “Convertible Security”) in the aggregate amount of $555,208.33. Mercer had previously converted the full $3,500,000 principal amount of the Convertible Security into Common Shares of the Company. Following this settlement, the only outstanding amount on the Convertible...

Continue reading

Ingredion Names Kenneth Escoe to Board of Directors

WESTCHESTER, Ill., June 11, 2026 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today announced that Kenneth Escoe has been appointed to its board of directors, effective July 1. “Kenneth will be a great addition to Ingredion’s board of directors,” said Jim Zallie, chairman, president and CEO, announcing Escoe’s election. “His track record of success leading capital-intensive businesses and transforming complex global operations across a range of commodity and specialty businesses will be a tremendous asset as we navigate our long-term growth strategy.” T. Kenneth Escoe is executive vice president of Specialty Products at Illinois Tool Works Inc. (ITW), a Fortune 500 global industrial manufacturer, a role he has held since...

Continue reading

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDNA alone GraftAssure™ assay doubles reliability of positive results in screening cohort In for-cause testing of kidney transplant patients, the positive predictive value using the CM-Score increased to greater than 80%NASHVILLE, Tenn., June 11, 2026 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced an online published article in the American Journal of Transplantation asserting statistical superiority of the company’s flagship GraftAssure transplant rejection monitoring assay. IMDx’s newly developed GraftAssure Combination Model (CM)-score mathematically combines the relative (percentage, or %) and absolute (copies per milliliter,...

Continue reading

Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced management’s presentation at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit. The presentation will be available on-demand beginning on Monday, June 15, 2026, at 7:00 a.m. ET. A webcast and archived replay of the Company’s presentation can be accessed under “Events and Presentations” in the Investor & Media Relations section of the Zenas BioPharma website. About Zenas BioPharma, Inc.Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader...

Continue reading

Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026

FAIRPORT, N.Y., June 11, 2026 (GLOBE NEWSWIRE) — Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the fourth quarter and twelve months ended March 31, 2026. Executive Summary (vs. year-ago, year-to-date results):Net sales for the twelve months ended March 31, 2026 totaled $1,659.7 million compared to $1,578.9 million for the twelve months ended March 31, 2025. The year-over-year increase of $80.8 million was due to higher sales volume, complemented by higher selling prices and product mix.    Gross margin as a percentage of net sales is 13.9% for the twelve months ended March 31, 2026, as compared to 9.5% for the twelve months ended March 31, 2025.“We completed fiscal 2026 with increases in unit volume as well as improving gross margins driven by more normalized pack costs in calendar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.